Home Biosimilar Antibodies Others Others antibody Naxitamab (Anti-GD2) For research use only.
Not for use in humans.

Naxitamab (Anti-GD2)

Synonyms: Naxitamab-gqgk; Humanized 3F8; Hu3F8

Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.

Naxitamab (Anti-GD2)

Purity & Quality Control

Batch: A248601 Purity: 99% Protein concentration: 9.48mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.

Product Details

CAS No. 1879925-92-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) supplier | purchase Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) cost | Naxitamab (Anti-GD2) manufacturer | order Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) distributor